These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6573317)

  • 1. Pharmacokinetics of single intravenous and intramuscular doses of cefotetan in normal human volunteers.
    Guibert J; Kitzis MD; Yvelin C; Acar JF
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():201-6. PubMed ID: 6573317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefotetan (YM09330) in humans.
    Nakagawa K; Koyama M; Tachibana A; Komiya M; Kikuchi Y; Yano K
    Antimicrob Agents Chemother; 1982 Dec; 22(6):935-41. PubMed ID: 6961888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tolerance of single intramuscular doses of cefotetan in normal Caucasian volunteers.
    Yates RA; Cockshott ID; Houghton HL; Wardleworth A; Adam H; Donnelly RJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():207-12. PubMed ID: 6573318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tolerance of single intravenous doses of cefotetan disodium in male Caucasian volunteers.
    Yates RA; Adam HK; Donnelly RJ; Houghton HL; Charlesworth EA; Laws EA
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():185-91. PubMed ID: 6573315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of cefotetan and an aminoglycoside preparation in combined administration. 1. Individual quantification of cefotetan and sisomicin by bioassay and their absorption, distribution, and excretion in rats when given together].
    Tachibana A; Ikeda C; Yano K
    Jpn J Antibiot; 1982 Jun; 35(6):1411-26. PubMed ID: 6957627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefotetan elimination in patients with varying degrees of renal dysfunction.
    Wright N; Wise R; Hegarty T
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():213-6. PubMed ID: 6573319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tolerance of a 24-h infusion of cefotetan disodium (with and without loading dose) in normal Caucasian volunteers.
    Adam HK; Houghton HL; Yates RA; Young J; Donnelly RJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():193-9. PubMed ID: 6573316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefotetan in elderly subjects after intramuscular administration.
    Ripa S; Mignini F; Prenna M
    Chemioterapia; 1987 Oct; 6(5):359-63. PubMed ID: 3480780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of cefotetan excretion in the unobstructed biliary tree.
    Owen AW; Manson JM; Yates RA; Adshead VM; Houghton HL; Tweedle DE
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():217-21. PubMed ID: 6573320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of a cefotetan and an aminoglycoside preparation in combined administration. 2. Absorption and exercise of cefotetan and sisomicin in dogs when the two are given together].
    Ikeda C; Tachibana A; Yano K
    Jpn J Antibiot; 1982 Jun; 35(6):1427-36. PubMed ID: 6957628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers.
    Parsons JN; Romano JM; Levison ME
    Antimicrob Agents Chemother; 1980 Feb; 17(2):226-8. PubMed ID: 6446259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function.
    Ohkawa M; Hirano S; Tokunaga S; Motoi I; Shoda R; Ikeda A; Sugata T; Sawaki M; Shimamura M; Okasho A; Kuroda K
    Antimicrob Agents Chemother; 1983 Jan; 23(1):31-5. PubMed ID: 6572490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute bioavailability and noncompartmental analysis of intravenous and intramuscular Cefotan (cefotetan) in normal volunteers.
    Zimmerman J; Cohen A; Thyrum P
    J Clin Pharmacol; 1989 Feb; 29(2):151-7. PubMed ID: 2715372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefotetan pharmacokinetics in volunteers with various degrees of renal function.
    Smith BR; LeFrock JL; Thyrum PT; Doret BA; Yeh C; Onesti G; Schwartz A; Zimmerman JJ
    Antimicrob Agents Chemother; 1986 May; 29(5):887-93. PubMed ID: 3460524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects.
    Israel KS; Black HR; Brier GL; Wolny JD; DeSante KA
    Antimicrob Agents Chemother; 1982 Jul; 22(1):94-102. PubMed ID: 6214998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of new broad-spectrum cephamycin, YM09330, parenterally administered to various experimental animals.
    Komiya M; Kikuchi Y; Tachibana A; Yano K
    Antimicrob Agents Chemother; 1981 Aug; 20(2):176-83. PubMed ID: 6945066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP
    Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers.
    Srinivasan S; Fu KP; Neu HC
    Antimicrob Agents Chemother; 1981 Feb; 19(2):302-5. PubMed ID: 6214989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of cefotetan.
    Martin C; Thomachot L; Albanese J
    Clin Pharmacokinet; 1994 Apr; 26(4):248-58. PubMed ID: 8013159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal pharmacokinetics and toxicology of cefotetan--a new cephamycin antibiotic.
    Suzuki H; Imamura K; Yoshida T; Shibata M; Matsuzawa T; Ozaki H; Sakai T; Shiobara Y; Tachibana A; Yano K
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():179-83. PubMed ID: 6573314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.